Roche, McKinsey and OrbiMed Launch First Life Sciences Business Plan Competition In Shanghai
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - Swiss-headquartered Roche, business consulting company McKinsey and venture capitalist OrbiMed co-launched Dec.10 their Shanghai SEED competition to foster entrepreneurs in China's life sciences sector
You may also be interested in...
Roche, OrbiMed And McKinsey's Entrepreneurship Competition Builds Platform For China's Young Biotech Community
SHANGHAI - Seeking ways to tap into China's rich talent pool and spark local innovation, Roche, OrbiMed and McKinsey are hoping a SEED business competition can nurture entrepreneurs in China's biotech academic community
Roche, OrbiMed And McKinsey's Entrepreneurship Competition Builds Platform For China's Young Biotech Community
SHANGHAI - Seeking ways to tap into China's rich talent pool and spark local innovation, Roche, OrbiMed and McKinsey are hoping a SEED business competition can nurture entrepreneurs in China's biotech academic community
PPD Continues High-speed Expansion In Asia With Second Acquisition Of A China-based CRO This Quarter
BEIJING - As part of a rapid-fire expansion across Asia, the U.S.-headquartered PPD has outlined plans to purchase and merge with the Beijing-based contract research organization BioDuro